COMMUNIQUÉS West-GlobeNewswire
-
Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
28/04/2026 -
Spectral AI Schedules 2026 First Quarter Financial Results and Conference Call
28/04/2026 -
Glass House Brands Reports Preliminary Unaudited First Quarter Financial Results, Updates FY2026 Guidance and Schedules Earnings Conference Call
28/04/2026 -
Nyxoah to Release First Quarter 2026 Financial Results on May 12, 2026
28/04/2026 -
ASAP Dental Care Sets New Benchmark in Clinical Excellence with Over 229,000 Successful Procedures Performed
28/04/2026 -
Galapagos’ Shareholders Adopt All Resolutions Proposed by the Board of Directors at the Annual and Extraordinary Shareholders’ Meetings 2026
28/04/2026 -
Chaque minute compte : l’EAACI appelle à une action urgente pour garantir à l’école la sécurité des enfants exposés au risque d’anaphylaxie
28/04/2026 -
CORRECTION -- Quoin Pharmaceuticals Provides Clinical and Regulatory Update for QRX009 Topical Rapamycin Development Programs
28/04/2026 -
EssilorLuxottica: EssilorLuxottica 2026 Annual Shareholders’ Meeting
28/04/2026 -
EssilorLuxottica: Assemblée générale 2026 d’EssilorLuxottica
28/04/2026 -
Disclosure of transparency notification from BlackRock, Inc.
28/04/2026 -
FDA Announces Major Steps to Implement Real-Time Clinical Trials
28/04/2026 -
The Aesthetic Show Celebrates 19 Years of Innovation, Education, and Excellence in Aesthetic Medicine — Announces Expanded 2026 Event in Las Vegas, June 25 - 28
28/04/2026 -
Axe Compute to Present at the Market Movers Investor Summit and the D. Boral Capital 2026 Global Conference
28/04/2026 -
NBPure Launches Exclusive MagO7 60-Count at Walmart, Expanding Access to Its Best-Selling Gut Cleanse
28/04/2026 -
Nexalin Announces Peer-Reviewed Publication with Neuroimaging Data in Psychotherapy and Psychosomatics Highlighting Brain-Network Effects and Clinical Improvement in Chronic Insomnia
28/04/2026 -
Invitation to the presentation of ALK’s first quarter 2026 results on Tuesday, 5 May 2026
28/04/2026 -
Clariane annonce le succès de son offre de 230 millions d’euros d’obligations senior additionnelles
28/04/2026 -
MiniMed announces Health Canada License for Simplera Sync™ Sensor, Type 2 Diabetes Indication with MiniMed™ 780G System
28/04/2026
Pages